|
|
|
Volumn 127, Issue 2, 2000, Pages 237-
|
|
Subacute cutaneous lupus erythematosous and interferon beta-1a;Lupus cutane erythemateux subaigu et interferon beta-1a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BETA1A INTERFERON;
COMPLEMENT COMPONENT C3;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
INTERFERON BETA SERINE;
BETA INTERFERON;
IMMUNOLOGICAL ADJUVANT;
ADULT;
AUTOIMMUNITY;
CASE REPORT;
DRUG SAFETY;
HUMAN;
SHORT SURVEY;
SKIN LUPUS ERYTHEMATOSUS;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG SURVEILLANCE PROGRAM;
MALE;
MULTIPLE SCLEROSIS;
ADJUVANTS, IMMUNOLOGIC;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
HUMANS;
INTERFERON-BETA;
LUPUS ERYTHEMATOSUS, CUTANEOUS;
MALE;
MULTIPLE SCLEROSIS;
|
|
EID: 0034137857
PISSN: 01519638
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
|
Times cited : (6)
|
|
References (1)
|
